Navigation Links
Accelrys Transforms Innovation by Bridging Cheminformatics and Bioinformatics

SAN DIEGO, Sept.10, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the completion of an initiative to standardize chemical structure perception across the Accelrys Enterprise Platform and the Accelrys Direct data cartridge for Oracle. Harmonized cheminformatics technology from Accelrys enables scientists to represent molecules, reactions, biologics and conjugates consistently across applications developed using the Accelrys Enterprise Platform and Accelrys Direct.

New releases of Accelrys Chemical Registration and Accelrys Biological Registration leverage the capabilities of Accelrys Direct to provide consistent registration of small molecules, biologics, chemically modified biologics and conjugates. The Accelrys registration applications enable organizations to capture and secure intellectual property (IP) pertaining to molecules and biologics in an environment that improves efficiency, protects IP, lowers costs associated with the unnecessary production of duplicate entities and improves traceability for regulatory agencies.

"With pharma and biotech companies moving to portfolios spanning small molecules, biologics and antibodies, medicinal chemists and molecular biologists must register and track an extensive set of entities," said Matt Hahn, Ph.D., senior vice president and chief technology officer, Accelrys. "The Accelrys Cheminformatics Suite, anchored by Accelrys Direct and our chemical and biological registration applications, meets customers' fundamental needs for end-to-end combined chemical and biologics acquisition, registration and management in today's increasingly integrated chemical and biological R&D environment."

The Accelrys Direct data cartridge ensures the fidelity of chemical information across Accelrys solutions and enables multidisciplinary project teams to explore novel chemical structures and macromolecular sequences stored in a single corporate registry. Accelrys Direct offers proven performance with databases containing more than 69 million structures and more than 17 million reactions. Accelrys Direct 9.0 provides harmonized chemistry representation, perception and search with Accelrys Enterprise Platform 9.0 along with other new features and enhancements. The Accelrys Enterprise Platform is the foundation for Accelrys' scientific software and services, enabling organizations to access and gain value from complex data across the enterprise and to integrate and deploy broad scientific solutions from research and development through quality control and manufacturing.

Built on the Accelrys Enterprise Platform, Accelrys Chemical Registration is a flexible, fully featured, out-of-the-box solution for building, managing and searching corporate substance and batch data bases, enabling researchers to register single substances, load SDfiles and leverage comprehensive functionality to meet multiple registration needs. Accelrys Chemical Registration 3.2 provides an interface to the Accelrys Electronic Lab Notebook that enables direct registration from an experiment. The latest release also supports data mirroring to Accelrys ISIS- and Isentris-based registration systems in addition to existing support for mirroring to Accelrys Accord-based enterprise informatics registration systems.

Accelrys Biological Registration enables biologists to register, search and report on a variety of biological entities including antibodies, hybridomas, cell lines, plasmids, proteins, siRNAs, yeasts, vaccines and more. Built in close collaboration with top pharmaceutical companies, this award-winning system helps manage intellectual assets, improve operational efficiency and can be readily extended to meet specific customer needs without writing code. Accelrys Biological Registration 3.1 provides new capabilities for defining chemically modified biological entities such as PEGylated peptides and antibody drug conjugates through support of chemical structure attributes, chemistry attribute rules and chemistry searching.

To learn more about the Accelrys Cheminformatics Suite and our next-generation collaborative discovery research solution, join us at the 11th Annual Pharmaceutical IT Congress, Sept. 23-24, in London. Rob Brown, Ph.D., senior director life sciences product management and marketing, will present on Accelrys' "Next Generation Cheminformatics Suite for Enhancing R&D Productivity and Innovation" on Monday, Sept. 23 at 12.20 p.m.

To learn more about Accelrys Biological Registration and its capabilities to register chemically modified biologics, sign up for a complimentary webinar to be held on Tuesday, Dec. 10 at 8 a.m. PST entitled "Accelrys Transforms Innovation by Bridging Cheminformatics and Bioinformatics."  

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit



Related Links
Learn more about Accelrys Direct 
Learn more about Accelrys Chemical Registration 
Learn more about Accelrys Biological Registration 
Accelrys Website 
Follow Accelrys on Twitter 
Friend Accelrys on Facebook 
Connect with Accelrys on LinkedIn 
Accelrys' YouTube Channel

Image with caption: "Browsing hit lists generated from running queries in Accelrys Biological Registration." Image available at:

Image with caption: "Viewing sequence and associated information used to determine the identity of a registered protein in Accelrys Biological Registration." Image available at:

Image with caption: "Accelrys Chemical Registration 3.2 supports enhanced stereochemistry." Image available at:

SOURCE Accelrys, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software for Improved Quality Control and Regulatory Compliance
2. Accelrys Announces Strategic Partnership with USDM
3. Accelrys Materials Studio Release 6.1 Speeds Innovation with Enterprise Capabilities
4. Society for Women’s Health Research IMAGINES IT -- SWHR’s Annual Gala Imagines the Future: Information Technology (IT) Transforms Women’s Healthcare
5. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
6. Patents: A Window into Innovation
7. Cambridge Semantics to Present on ‘Smart Data’ During Deep-Dive Workshop at 2013 Big Data Innovation Summit
8. Bayer CropScience Celebrates 150 Years of Innovation; Asks for 150 Perspectives on the Future of Farming
9. Nanounity Announces That the Delmic SECOM Correlative Microscopy System Has Won a 2013 Microscopy Today Innovation Award.
10. OP Innovations Introduces Easy-to-Use Bio-Sensor to Help Users Manage Stress -- The ReLax Kit
11. Prism Awards Winners Keep Spotlight on Photonics Innovation
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... Worcester, Mass. (PRWEB) , ... November 24, 2015 ... ... need to maintain healthy metabolism. But unless it is bound to proteins, copper ... Institutes of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/27/2015)... Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ... so that they can be quantitatively analyzed with SMI,s ... Germany , October 28-29, 2015. SMI,s Automated Semantic ... eye tracking videos created with SMI,s Eye Tracking ...
Breaking Biology News(10 mins):